Induction of IL-4 by platelet-activating factor

Clinical and Experimental Immunology

Volumn 106, Issue 1, 1996, Pages 143-148

  Huang, Y H ^a   Schafer Elinder L ^b   Owman, H ^a   Lorentzen, J C ^a   Ronnelid J ^a   Frostegard J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antibodies; IL 4; IL 6; Platelet activating factor; T lymphocyte

Indexed keywords

BEPAFANT; INTERLEUKIN 4; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; THROMBOCYTE ACTIVATING FACTOR;

ADULT; ARTICLE; ASTHMA; ATHEROSCLEROSIS; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VASCULITIS;

EID: 0029782857     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-813.x     Document Type: Article

References (44)

1. Tokumura A. A family of phospholipid autacoids: occurrence, metabolism and bioactions. Prog Lipid Res 1995; 34:151 84.
2. Bussolino F, Camussi G. Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties, Eur J Biochem 1995; 229:327 37.
3. McManus LM, Woodard DS, Deavers SI, Pinckard RN. PAF molecular heterogeneity: pathobiological implications, Lab Invest 1993; 69:639 50.
4. Kunz D, Gerard NP, Gerard CJ. The human leukocyte plateletactivating factor receptor: cDNA cloning, surface expression, and construction of a novel epitopc-hearing analog. J Biol Chem 1992; 267:9101-6.
5. Simon HU, Tsao PW, Siminovitch KA, Mills GB, Blaser K. Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma. J Immunol 1994; 153:364 77.
6. Tjoelker LW, Wilder C, Eberhardt C et al. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 1995; 374:549 53.
7. Warren JS, Mandel DM, Johnson KJ, Ward PA. Evidence for the role of platelet-activating factor in immune complex vasculitis in the rat. J Clin Invest 1989; 83:669 78.
8. Braquet P, Hosford D, Braquet M, Bourgain R, Bussolino F. Role of cytokines and platelet-activating factor in microvascular immune injury. Int Arch Allergy Appl Immunol 1989; 88:88 100.
9. Yamamoto H, Nagata M, Tabe K, Kimura I, Kiuchi H, Sakamoto Y, Yamamoto K, Dohi Y. The evidence of platelet activation in bronchial asthma. J Allergy Clin Immunol 1993; 91:79 87.
10. Feliste R, Perret B, Braquet P, Chap H. Protective effect of BN 52021, a specific antagonist of platelet-activating factor (PAF-acether), against diet-induced cholesteryl ester depostion in rabbit aorta. Atherosclerosis 1989; 78:151 8.
11. Evangelou AM. Platelet-activating factor (PAF): implications for coronary heart and vascular diseases. Prostaglandins, leukotrienes and essential fatty acids. 1994; 50:1 28.
12. Mueller HW, Haught CA, Mcnatt JM, Cui K, Gaskell S, Johnston DA, Willerson JT. Measurement of PAF in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease. Circ Res 1995; 77:54 63.
13. Bonavida B, Mencia-Huerta JM, Braquet P. Effect of plateletactivating factor (PAF) on monocyte activation and production of tumor necrosis factor, Int Arch Allergy Applied Immunol 1989: 88:157 60.
14. Poubelle PE, Gingras D, Deners C, Dubois C. Harbour D, Grassi J. Platelet-activating factor (PAF-acether) enhances the concomitant production of TNF-a and IL-1 by subsets of human monocytes. Immunology 1991; 72:181 7.
15. Thivierge M, Rola-Pleszcynski M. PAF enhances IL-6 production by alveolar macrophages. J Allergy Clin Immunol 1992: 90:796.
16. Heuer H, Birke F, Brandt K, Muacevic G, Weber KH. Biological characterisation of the enantiomeric hetrazepines of the PAF-antagonist WEB 2170. Prostaglandins 1988; 35:847.
17. Rönnelid J, Huang YH. Norrlander T, Rogberg S, Nilsson B, Gustafsson R, Klareskog L. Short term kinetics of the humoral anti-Clq response in SLE using the ELISPOT method: fast decline in production in response to steroids. Scand J Immunol 1994; 40:243 50.
18. Czerkinsky C, Nilsson LÅ, Nygren H, Ouchterlony Ö. Tarkowski A. A solid-phase enzyme linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 1983; 65:109 21.
19. Kabilan L, Andersson G, Lolli F, Ekre HP, Olsson T, Troye-Blomberg M. Detection of intracellular expression and secretion of interferon-gamma at the single cell level after activation of human T cells with tetanus toxoid in ritro. Eur J Immunol 1990; 20:1085 9.
20. Czerkinsky C, Andersson G, Ekre HP, Nilsson LA, Klareskog L, Ouchterlony Ö. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Immunol Methods 1988; 110:29 36.
21. Huang YH, Rönnelid J, Frostegård J. Oxidized LDL induces enhanced antibody formation and MHC class II-dependent IFN-gamma production in lymphocytes from healthy individuals. Arteriosclerosis. Thrombosis and Vasc Biol 1995; 15:1577 83.
22. Coulie PG, Van Snick J, Enhancement of IgG anti-carrier responses by IgG2 anti-hapten antibodies in mice. Eur J Immunol 1985: 15:793 8.
23. Burdin N, Van Kooten C, Galibert L, Abrams JS, Wijdenes J, Banchereau J, Rousset F, Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J Immunol 1995; 154:2533 44.
24. Denizot Y, Dupuis F, Praloran V. Effect of PAF on human T and B cells. Rev Immunol 1994; 145:109 11.
25. Behrens TW, Goodwin J. Control of human T cell proliferation by platelet-activating factor, Int J Immunopharmacol 1990; 12: 175 84.
26. Dulioust A, Duprez V, Pitton C, Salem P, Hemar A, Benveniste J, Thomas Y. Immunoregulatory functions of PAF-acether III. Down-regulation of CD4 T cells high affinity IL-2 receptor expression. J Immunol 1990; 144:3123 9.
27. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of a lipid antigen by CD1 restricted AB T cells. Nature 1995; 372:691 4.
28. Kiessling R, Grönberg A, Ivanyi J, Söderströni K, Ferm M, Kleinau S, Nilsson E, Klareskog L. Role of hsp60 during autoimmune and bacterial inflammation. Immunol Rev 1991; 12:91 111.
29. Frostegård J, Kjellman B, Gidlund M, Andersson B, Jindal S, Kiessling R. Induction of heat shock protein in monocytic cells by oxidized low density lipoprotein. Atherosclerosis 1996;
30. Korth R, Zimmermann K, Richter WO. Lipoprotein-associated paf (LA-paf) was found in washed human platelets and monocyte macrophage-like U937 cells. Chem Phys Lipids 1994; 70:109 19.
31. Lamb JR, Bal V, Mendez-Sampeiro P et al. Stress proteins may provide a link between the immune response to infection and autoimmunity. Int Immunol 1989; 1:1 .
32. Koga T, Wand-Wurttenberger A, De Bruyn J, Munk ME, School B, Kaufmann SH. T cells against a bacterial heat shock protein recognize stressed macrophages. Science 1989; 245:1112 5.
33. Huang YH, Haegerstrand A, Frostegård J. Effects of in vitro hyperthermia on proliferative responses and lymphocyte activity. Clin Exp Immunol 1996; 103:61 67.
34. Gascan H, Gauchat JF, Roncarolo MG, Yssel H, Spits H, de Vries JE. Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4 T cell clones. J Exp Med 1991; 173:747 50.
35. Bradding P, Roberts JA, Britten KM et al. Interleukin-4. -5. and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471 80.
36. Kurosawa M, Yamashita T, Kurimoto F. Increased levels of blood platelet-activating factor in bronchial asthmatic patients with active symptoms. Allergy 1994; 49:60 63.
37. Nassar GM, Morrow JD, Roberts LJ, Lakkis FG, Badr KF. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J Biol Chem 1994; 269:27631 4.
38. Conrad DJ, Kühn H, Mulkins M, Highland E, Sigal E. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sci USA 1995; 89:217 21.
39. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzturn JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Eng J Med 1989; 320:915 24.
40. Shannon VR, Chanez P, Bousquet J, Holtzman MJ. Histochemical evidence for induction of arachidonate 15-lipoxygenase in airway disease. Am Rev Respir Dis 1993; 147:1024 8.
41. Yla-Herttuala S, Luoma J, Viita H, Hiltunen T, Sisto T, Nikkari T. Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein. J Clin Invest 1995; 95:2692 8.
42. Parronchi P. De Carli M, Manetti R et al. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol 1492; 149:2977 83.
43. van der Pouw-Kraan T, de Jong R, Aarden L. Development of human Th2 and Th2 cytokine responses: the cytokine production profile of T cells is dictated by the primary in vitro stimulus. Eur J Immunol 1993; 23:1 5.
44. Rook GA, Onyebujoh P, Stanford JL. TH1 TH2 switching and loss of CD4 T cells in chronic infections: an immunoendocrinological liypothesis not exclusive to HIV. Immunol Today 1993; 14:568 9.